Development of specific cell therapy to treat neurological diseases

Forschungsstelle

INNOSUISSE

Projektnummer

48812.1 IP-LS

Projekttitel

Development of specific cell therapy to treat neurological diseases

Projekttitel Englisch

Development of specific cell therapy to treat neurological diseases

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung		-	-
Abstract		-	-	-

Kategorie	Text
Kurzbeschreibung (Deutsch)	Development of specific cell therapy to treat neurological diseases
Kurzbeschreibung (Englisch)	Development of specific cell therapy to treat neurological diseases
Abstract (Deutsch)	Chimeric structure of astrocytic specific chaperone and GliaPharm#s lead molecules will be designed by Prof. Raymond evaluated by Prof. Volterra and their potency as drug tested in GliaPharm#s laboratory in a preclinical mouse models including refractory epilepsy.